What is Aurinia Pharmaceuticals's investing cash flow?

Aurinia Pharmaceuticals (AUPH) reported investing cash flow of -$18.08M in Q1 2026.

How has Aurinia Pharmaceuticals's investing cash flow changed year-over-year?

Aurinia Pharmaceuticals's investing cash flow decreased by 158.3% year-over-year, from $31.03M to -$18.08M.

What does investing cash flow mean?

Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.

Aurinia Pharmaceuticals AUPH Investing Cash Flow

Investing Cash Flow at other companies

Rogers CorporationROG

-$4.5M-215%

Vera TherapeuticsVERA

-$137.82M-1,000%

ANI PharmaceuticalsANIP

-$11.32M+42.9%

Ultragenyx PharmaceuticalRARE

-$49M-141%

Agios PharmaceuticalsAGIO

$141.31M+25.5%

Kiniksa Pharmaceuticals International, plcKNSA

-$31.92M+38.1%

Other financials

Income statement

See full

Revenue$77.7M+24.4%

Gross profit$71.2M+32.1%

Operating income$41.4M+89.6%

Net income$34.4M+47.2%

EPS (diluted)$0.25+56.3%

Balance sheet

See full

Cash & equivalents$41.0M-38.3%

Total debt$85.2M-7.9%

Total equity$567.6M+62.1%

Total assets$724.0M+43.4%

Cash flow

See full

Operating cash flow$32.6M+2,405%

Valuation

See full

Market cap$2.3B+78.5%

Enterprise value$2.34B+78.3%

P/E7.7×-24.6×

P/S7.7×+2.5×

Profitability

See full

Gross margin89.7%+1.5pp

Operating margin41.7%+29.4pp

Net margin100%+83.9pp

Returns & leverage

See full

Return on equity65%+53.8pp

Debt / equity0.2×-0.1×

Current ratio5.5×-0.4×

Where this comes from

Reported directly by Aurinia Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The official record: Aurinia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Aurinia Pharmaceuticals's investing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Aurinia Pharmaceuticals's investing cash flow?: Aurinia Pharmaceuticals (AUPH) reported investing cash flow of -$18.08M in Q1 2026.
How has Aurinia Pharmaceuticals's investing cash flow changed year-over-year?: Aurinia Pharmaceuticals's investing cash flow decreased by 158.3% year-over-year, from $31.03M to -$18.08M.
What does investing cash flow mean?: Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.